Meta-Analysis: Interleukin Inhibitors Increase the Risk of Infections and Cancer in Patients with Rheumatologic Diseases
22 Oct, 2019 | 07:38h | UTCCommentary: Interleukin Targeted Biologics Increase Risks of Infection – RheumNow (free)
Commentary: Interleukin Targeted Biologics Increase Risks of Infection – RheumNow (free)